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abstract
 
The gating modiﬁer toxins are a large family of protein toxins that modify either activation or inacti-
 
vation of voltage-gated ion channels. 
 
v
 
-Aga-IVA is a gating modiﬁer toxin from spider venom that inhibits voltage-
 
gated Ca
 
2
 
1
 
 channels by shifting activation to more depolarized voltages. We identiﬁed two Glu residues near the
COOH-terminal edge of S3 in the 
 
a
 
1A
 
 Ca
 
2
 
1
 
 channel (one in repeat I and the other in repeat IV) that align with
Glu residues previously implicated in forming the binding sites for gating modiﬁer toxins on K
 
1
 
 and Na
 
1
 
 chan-
nels. We found that mutation of the Glu residue in repeat I of the Ca
 
2
 
1
 
 channel had no signiﬁcant effect on inhi-
bition by 
 
v
 
-Aga-IVA, whereas the equivalent mutation of the Glu in repeat IV disrupted inhibition by the toxin.
 
These results suggest that the COOH-terminal end of S3 within repeat IV contributes to forming a receptor for 
 
v
 
-Aga-
IVA. The strong predictive value of previous mapping studies for K
 
1
 
 and Na
 
1
 
 channel toxins argues for a con-
served binding motif for gating modiﬁer toxins within the voltage-sensing domains of voltage-gated ion channels.
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INTRODUCTION
 
The voltage-gated K
 
1
 
, Na
 
1
 
, and Ca
 
2
 
1
 
 channels are a
large family of membrane proteins that share many
structural features (Armstrong and Hille, 1998; Catter-
all, 2000). Voltage-gated K
 
1
 
 channels are formal tet-
 
ramers with each 
 
a
 
 subunit containing six (S1–S6)
transmembrane segments, all of which seem to be
membrane-spanning 
 
a
 
-helices (Doyle et al., 1998; Mac-
Kinnon et al., 1998; Monks et al., 1999; Hong and
Miller, 2000; Li-Smerin et al., 2000). A central pore do-
main, which contains the ion conduction pathway, is
formed by the tetrameric arrangement of the S5–S6 re-
gions (Doyle et al., 1998; MacKinnon et al., 1998). Four
equivalent voltage-sensing domains, each composed of
the ﬁrst four segments (S1–S4), surround the central
pore domain (for review see Li-Smerin et al., 2000). In
voltage-gated Na
 
1
 
 and Ca
 
2
 
1
 
 channels, the general ar-
chitecture is similar to K
 
1
 
 channels, with the difference
being that each 
 
a
 
 subunit contains four repeating psue-
dosubunits, each resembling a single K
 
1
 
 channel 
 
a
 
 sub-
unit (Catterall, 1996; Armstrong and Hille, 1998; Cat-
terall, 2000). Although the four internal repeats in volt-
age-gated Ca
 
2
 
1
 
 and Na
 
1
 
 channel 
 
a
 
 subunits are
homologous, they are not identical.
Venomous animals produce an almost limitless array
of different protein toxins, many of which interact with
voltage-gated ion channels. Some protein toxins bind
to the outer vestibule of the ion conduction pore, and
they are thought to inhibit the channel by physically oc-
cluding ion conduction (Hille, 1992; Miller, 1995; Cat-
terall, 1996). Other types of protein toxins interact with
very different regions of voltage-gated ion channels
and perturb channel function by a distinct mechanism.
These toxins are known as gating modiﬁers because
they perturb the energetics of either activation or inac-
tivation gating. The protein toxins that are established
 
gating modiﬁers include the following: the 
 
a
 
- and
 
b
 
-scorpion toxins, sea anemone toxins, and 
 
d
 
-conotox-
ins for Na
 
1
 
 channels (Cahalan, 1975; Catterall, 1979;
Wang and Strichartz, 1983; Meves et al., 1986; Stri-
chartz and Wang, 1986; Gonoi and Hille, 1987; Norton,
1991; Fainzilber et al., 1994, 1995; Shon et al., 1994;
Hanck and Sheets, 1995; Rogers et al., 1996; Cestele et
al., 1998); Hanatoxin for K
 
1
 
 channels (Swartz and
MacKinnon, 1997a,b; Li-Smerin and Swartz, 1998,
2000; Swartz, 1999); and 
 
v
 
-Aga-IVA, Grammotoxin, and
Kurtoxin for Ca
 
2
 
1
 
 channels (Mintz et al., 1992a,b;
Lampe et al., 1993; McDonough et al., 1997a,b;
Chuang et al., 1998).
Suppose that gating modiﬁer toxins interact exclu-
sively with the voltage-sensing domains, as seems to be
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the case for Hanatoxin and voltage-gated K
 
1
 
 channels
(Li-Smerin and Swartz, 2000). Even in this case, there
should be ample surface area on the extracellular sur-
face of these domains to allow different gating modiﬁer
toxins to interact in unique ways with the voltage-sens-
ing domains, possibly having few, if any, interacting
pairs of residues in common. However, mapping stud-
ies show that homologous Glu residues in the COOH
terminus of S3 in a K
 
1
 
 channel, and the equivalent re-
gion of repeat IV in a Na
 
1
 
 channel, are important de-
terminants for Hanatoxin binding to the K
 
1
 
 channel
(Swartz and MacKinnon, 1997b; Li-Smerin and Swartz,
2000) and both 
 
a
 
-scorpion and sea anemone toxin
binding to the Na
 
1
 
 channel (Rogers et al., 1996). This
suggests that the K
 
1
 
 channel toxin and the Na
 
1
 
 chan-
nel toxins interact with very similar regions of their re-
spective channels.
To further examine the generality of these results, we
asked whether a gating modiﬁer toxin for a voltage-
gated Ca
 
2
 
1
 
 channel would interact with the same re-
gion. The best studied gating modiﬁer toxin for Ca
 
2
 
1
 
channels is 
 
v
 
-Aga-IVA (a protein toxin from spider
venom) that inhibits P-type Ca
 
2
 
1
 
 channel by shifting ac-
tivation to more depolarized voltages (Mintz et al.,
1992a,b; McDonough et al., 1997b). From the biophysi-
cal properties of the 
 
v
 
-Aga-IVA–Ca
 
2
 
1
 
 channel interac-
 
tion, we would predict that this toxin interacts with at
least one of the voltage-sensing domains of the chan-
nel, which is similar to Hanatoxin and both 
 
a
 
-scorpion
and sea anemone toxins (Rogers et al., 1996; Swartz
and MacKinnon, 1997a,b; Li-Smerin and Swartz, 2000).
In this case, there could be anywhere from one to four
 
v
 
-Aga-IVA receptors per channel because the Ca
 
2
 
1
 
channel contains four nonidentical voltage-sensing do-
mains. The sequence alignment in Fig. 1 identiﬁes two
Glu residues in the 
 
a
 
1A
 
 Ca
 
2
 
1
 
 channel (the cloned 
 
a
 
 sub-
unit of native P-type channels), one in repeat I and the
other in repeat IV, that correspond to the Glu residues
in K
 
1
 
 and Na
 
1
 
 channels previously found to alter the
binding of gating modiﬁer toxins to these channels
(Rogers et al., 1996; Swartz and MacKinnon, 1997b; Li-
Smerin and Swartz, 2000). The Glu residue in repeat IV
is of particular interest because insertion of Asn and
Pro at the nearby position marked by the black arrow in
Fig. 1 has been reported to decrease 
 
v
 
-Aga-IVA afﬁnity
by 
 
z
 
10-fold (Bourinet et al., 1999; Hans et al., 1999).
We mutated each of these two Glu residues and as-
sessed the effects on the interaction between 
 
v
 
-Aga-IVA
and the Ca
 
2
 
1
 
 channel. Our results support the general
idea that gating modiﬁer toxins interact with a similar
region of the voltage-sensing domains in different volt-
age-gated ion channels.
Figure 1. Sequence com-
parison between voltage-
gated ion channels in the gat-
ing modiﬁer toxin binding
region. Membrane folding
model for a K1 channel a
subunit and sequence align-
ment between K1, Ca21, and
Na1 channels in S3–S4. Cylin-
ders demarcate the approxi-
mate positions of a-helices
based on scanning mutagene-
sis in both Shaker and drk K1
channels (Monks et al., 1999;
Hong and Miller, 2000; Li-
Smerin et al., 2000). Under-
lined region of sequence
marks approximate trans-
membrane segments identi-
ﬁed by hydrophobicity analy-
sis. The three positions high-
lighted in yellow correspond
to positions in the drk1 K 1
channel (Ile273, Phe274, and
Glu277) where mutations al-
ter Hanatoxin afﬁnity (Swartz
and MacKinnon, 1997b; Li-
Smerin and Swartz, 1998,
2000). Mutation of Glu1613 in repeat IV of the Na1 channel (highlighted yellow) decreases the binding afﬁnity of a-scorpion and sea
anemone toxins (Rogers et al., 1996). In the a-1A Ca21 channel, two repeats contain Glu residues (Glu188 and Glu1658; marked by yellow
highlighting and the red box) at positions corresponding to Glu277 in the drk1 K1 channel and Glu 1613 in the brain IIA Na1 channel.
The black arrow under the sequence for repeat IV in the a-1A Ca21 channel marks the position where insertion of Asn and Pro has been re-
ported to decrease v-Aga-IVA afﬁnity (Bourinet et al., 1999; Hans et al., 1999). 
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MATERIALS AND METHODS
 
Molecular Biology
 
cDNAs encoding rabbit brain 
 
a
 
1A
 
 (BI-1) (Mori et al., 1991), rat
brain 
 
b
 
1b
 
 (Pragnell et al., 1991), and rabbit skeletal muscle 
 
a
 
2
 
d
 
(Ellis et al., 1988) were provided by Lutz Birnbaumer (University
of California, Los Angeles, Los Angeles, CA) in the pAGA2 vector
(Wei et al., 1991). Point mutations were introduced into the 
 
a
 
1A
 
cDNA by synthesizing mutant fragments using PCR, ligating into
appropriately digested vectors, and sequencing using an auto-
mated DNA sequencer. 
 
a
 
1A
 
 and 
 
a
 
2
 
d
 
 were linearized with XhoI,
and 
 
b
 
1b
 
 was linearized with HindIII. All subunits were transcribed
using T7 RNA polymerase.
 
Electrophysiology
 
Oocytes from 
 
Xenopus laevis
 
 frogs were removed surgically and in-
cubated with agitation for 1.5 h in a solution containing: 82.5
mM NaCl, 2.5 mM KCl, 1 mM MgCl
 
2
 
, 5 mM HEPES, and 2 mg/
ml collagenase (Worthington Biochemical Corp.), pH 7.6, with
NaOH. Defolliculated oocytes were injected with cRNA and incu-
bated at 17
 
8
 
C in a solution containing: 96 mM NaCl, 2 mM KCl, 1
mM MgCl
 
2
 
, 1.8 mM CaCl
 
2
 
, 5 mM HEPES, and 50 
 
m
 
g/ml genta-
micin (GIBCO BRL), pH 7.6, with NaOH for 1–7 d before electro-
physiological recording. Approximately equal quantities (
 
z
 
10–
100 ng) of cRNA for 
 
a
 
1A
 
, 
 
b
 
1b
 
, and 
 
a
 
2
 
d
 
 subunits were injected into
each oocyte. Oocyte membrane voltage was controlled using an
oocyte clamp (model OC-725C; Warner Instruments). Data were
ﬁltered at 2 kHz (8-pole Bessel) and digitized at 10 kHz. Micro-
electrode resistances were 0.1–0.8 M
 
V
 
 when ﬁlled with 3 M KCl.
Oocytes were studied in 160–200-
 
m
 
l recording chambers per-
fused with a solution containing the following: 1 mM BaOH
 
2
 
, 100
mM NaCH
 
3
 
SO
 
3
 
, and 10 mM HEPES, pH 7.6, with NaOH. Con-
tamination of Ca
 
2
 
1
 
 activated Cl
 
2
 
 current was minimized by re-
cording in Cl
 
2
 
-free solution and recording Ba
 
2
 
1
 
 currents usually
,2 mA (mostly z1 mA). 0.1 mg/ml21 BSA was included in the ex-
tracellular recording solution to minimize adsorption of the
toxin to the walls of the chamber and tubing. Agar salt bridges
containing 1 M NaCl were used to connect the ground electrode
pools and the recording chamber. All experiments were carried
out at room temperature (z22–258C). v-Aga-IV was purchased
from Calbiochem.
RESULTS
We studied the interaction of v-Aga-IVA with the a1A
Ca21 channel (Mori et al., 1991), the likely a subunit
for P-type channels in cerebellar Purkinje neurons
(Bourinet et al., 1999; Hans et al., 1999), expressed
along with b1b and a2d accessory subunits in Xenopus
oocytes. Fig. 2 shows the inhibitory effects of v-Aga-IVA
on the wild-type Ca21 channel when using 1 mM Ba21
as the charge carrier. At a concentration of 1 mM, v-Aga-
IVA produced nearly complete inhibition of Ba21
currents elicited by test depolarizations to 215 mV.
Even at this high toxin concentration, the rate of inhi-
bition was rather slow; for the example shown in Fig. 2
B, the ton for onset of inhibition was z50 s. Recovery of
the current after removal of the toxin from the record-
ing chamber was also slow, requiring that an oocyte be
held in voltage-clamp for z30 min to observe nearly
complete recovery. A single exponential ﬁt of the re-
covery in Fig. 2 B yielded a time constant of 370 s. The
relationship between the fraction of uninhibited cur-
rent and test voltage is shown in Fig. 2 C for several dif-
ferent toxin concentrations. With stronger test depolar-
izations, the fraction of uninhibited current increases.
This fractional increase most likely represents the
opening of toxin-bound channels at more depolarized
voltages and possibly also the more rapid dissociation
of the toxin from the open state (McDonough et al.,
1997b). In the negative voltage range, the fraction of
uninhibited current approaches a plateau value (Fig. 2
C). A similar plateau was observed at negative voltages
for the fraction of uninhibited current with the interac-
tion between Hanatoxin and a voltage-gated K1 chan-
nel, where deactivation kinetics were found to be simi-
lar in the absence or presence of the toxin (Swartz and
MacKinnon, 1997a). The results with Hanatoxin argue
that tail current kinetics distinguish between channels
opening with and without toxin molecules bound to
them and imply that, at negative voltages, the fraction
of uninhibited current approximates the fraction of
unbound channels. For the present analysis of v-Aga-
IVA, we used an approach similar to that described for
Hanatoxin, where the fraction of uninhibited current
in the plateau phase at negative voltages is used to esti-
mate the fraction of unbound channels at different
toxin concentrations (Swartz and MacKinnon, 1997a).
The fraction of uninhibited current at negative voltages
(225 to 215–mV range) is plotted against the concen-
tration of v-Aga-IVA in Fig. 2 D. An expression for 1:1
binding between toxin and channel was ﬁt to the data
with an equilibrium Kd of 160 nM.
We chose to mutate the two Glu residues in the a1A
Ca21 channel that we identiﬁed in the sequence align-
ment in Fig. 1 to Lys (Glu188Lys and Glu1658Lys), a
type of replacement that has particularly large effects
on a-scorpion toxin binding to the Na1 channel and
Hanatoxin binding to the K1 channel (Rogers et al.,
1996; Li-Smerin and Swartz, 2000). The gating proper-
ties of Glu188Lys and Glu1658Lys are shown in Fig. 3
along with the wild-type channel. Both mutants pro-
duce only subtle changes in the voltage–activation rela-
tion, with z10 mV rightward shifts in the conductance
(G)–voltage (V) relation with little change in the slope
of the voltage–activation relation. The effect of 1 mM
v-Aga-IVA on the wild-type and two mutant channels is
shown in Fig. 4 (A and B). The current records in Fig. 4
A were elicited with very similar protocols using depo-
larizations to either –15 or 210 mV from a holding po-
tential of 290 mV. 1 mM v-Aga-IVA inhibited the repeat
I mutant (Glu188Lys) and the wild-type channel to sim-
ilar extents. In contrast, the same toxin concentration
did not have a signiﬁcant effect on channels containing
the mutation in repeat IV (Glu1658Lys). Fig. 4 C shows640 Common Binding Sites for Gating Modifier Toxins
the concentration dependence for inhibition of the
three channels by v-Aga-IVA. The ﬁts of an equation
for 1:1 stoichiometry between toxin and channel to the
data for Glu188Lys and the wild-type channel yielded
Kd values of 110 and 160 nM, respectively. In contrast,
even at very high concentrations (4 mM),  v-Aga-IVA
produced only minimal inhibition of the Glu1658Lys
mutant channel. We estimate the dissociation constant
for toxin binding to the repeat IV mutant to be .33
mM, corresponding to a change in toxin binding afﬁn-
ity of z200-fold or greater. From these results, we con-
clude that v-Aga-IVA binds to a receptor on the voltage-
sensing domain within repeat IV of the Ca21 channel.
These results argue that equivalent Glu residues in the
COOH-terminal part of S3 are important determinants
of the gating modiﬁer toxin receptors in voltage-gated
K1, Na1, and Ca21 channels.
DISCUSSION
We set out to ﬁnd the location of the receptor for v-Aga-
IVA on a voltage-gated Ca21 channel using the informa-
tion already available for the location of gating modi-
ﬁer toxin receptors on Na1 and K1 channels. The
alignment of K1, Na1, and Ca21 channels from S3
through S4 identiﬁed two Glu residues in the a1A Ca21
channel (one in repeat I and the other in repeat IV)
that are equivalent to Glu277 in the drk1 K 1 channel
and Glu1613 in the brain IIA Na1 channel (Fig. 1). It
has been previously reported that insertion of Asn and
Pro (two positions COOH-terminal to Glu1658 in re-
peat IV of the a1A Ca21 channel) decreases v-Aga-IVA
afﬁnity, suggesting that a receptor for the toxin may be
located nearby (Bourinet et al., 1999; Hans et al.,
1999). We mutated each of these Glu residues (Glu188
and Glu1658) to Lys and studied the interaction be-
tween v-Aga-IVA and the Ca21 channel. Our results
show that Glu1658Lys disrupts inhibition by v-Aga-IVA,
whereas Glu188Lys has no discernible effect (Fig. 4).
This suggests that v-Aga-IVA interacts with the voltage-
sensing domain in repeat IV of the Ca21 channel and
that Glu1658 is a component of the toxin receptor. It is
rather remarkable that the a1A Ca21 channel subunit
contains .2,000 amino acids, yet it required only two
Figure 2. Inhibition of the
a1A Ca21 channel by v-Aga-
IVA. (A) Inhibition of Ca21
channel currents by v-Aga-
IVA. Current records elicited
by depolarization in either
the absence or presence of
toxin. Charge carrier was 1
mM Ba21. Leak and capaci-
tive currents have been iso-
lated and subtracted using
100  mM Cd to block the Ca21
channel. (B) Time course for
onset and recovery for inhibi-
tion by v-Aga-IVA. Steady
state Ba21 current elicited by
depolarizations to 215 mV at
10-s intervals before and after
application of the toxin. In-
ward Ba21 currents were mea-
sured 10 ms after depolariza-
tion. (C) Fraction of unin-
hibited current elicited by
various strength depolariza-
tions. Steady state Ba21 cur-
rents were elicited in the pres-
ence (I) or absence (I0) of
toxin using 30-ms depolariza-
tions between 225 and 125
mV. Holding voltage was 290
mV in all cases. Data are
means  6  SEM for three oo-
cytes at each toxin concentra-
tion. (D) Plot of fraction of
uninhibited ( ) current In/I
n
0
against toxin concentration.   is the fraction of uninhibited current in the plateau phase at negative voltages, typically –25 to –15 mV
(see C). Smooth curve is a ﬁt of   5 1 2 {[toxin]/ ([toxin] 1 Kd)} to the data, where Kd is the equilibrium dissociation constant for
toxin binding to a single site on the channel. Data are from means 6 SEM for between three and ﬁve oocytes at each toxin concentration.
In/I
n
0
In/I
n
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The idea of a canonical receptor for gating modiﬁer
toxins is further supported by several examples of gat-
ing modiﬁer toxins that interact promiscuously with
different types of voltage-gated ion channels. Hana-
toxin, a K1 channel inhibitor, is related in primary se-
quence to Grammotoxin, an inhibitor of voltage-gated
Ca21 channels, and both toxins can cross-react with the
other’s primary target (Li-Smerin and Swartz, 1998). In
addition, at least in the K1 channel, the binding of
both toxins is altered by mutations in the COOH-termi-
nal part of S3, arguing for a common binding site for
the two toxins (Li-Smerin and Swartz, 1998). Another
example of toxin promiscuity is seen with Kurtoxin, an
a-scorpion toxin that was isolated in a screen for activ-
ity against T-type voltage–gated Ca21 channels (Chuang
et al., 1998). Kurtoxin inhibits the T-type Ca21 channel
by shifting activation to more depolarized voltages,
reminiscent of both Hanatoxin and Grammotoxin.
However, Kurtoxin also interacts with voltage-gated
Na1 channels and slows their inactivation, similar to
other a-scorpion toxins to which it is related (Chuang
et al., 1998). These results are consistent with the idea
that gating modiﬁer toxins interact with a similar re-
gion of voltage-gated channels and that this region
adopts a well conserved 3-D structure.
Although the conserved Glu residues in voltage-
gated K1, Na1, and Ca21 channels probably mark the
location of the gating modiﬁer toxin binding sites,
there are certainly other residues located at the toxin–
channel interfaces that make signiﬁcant energetic con-
tributions. For the interaction of Hanatoxin with the
drk1 K1 channel, at least two other residues (Ile273 and
Phe274) contribute to form the toxin receptor (Li-
Smerin and Swartz, 2000). It is interesting that both of
these residues are well conserved in repeat IV of the
Na1 and Ca21 channels (Fig. 1), although the effects of
mutations at these positions on gating modiﬁer toxins
have not been reported. The 3-D structures of these
gating modiﬁer toxins (Widmer et al., 1989; Yu et al.,
1993; Jablonsky et al., 1995; Kim et al., 1995; Monks et
al., 1995; Reily et al., 1995; Takahashi et al., 2000) sug-
gests that the toxin–channel interaction surfaces are
probably somewhere between 20 3 20 Å and 30 3 30 Å
in size, arguing that many channel residues will be bur-
ied in the toxin–channel complex. Whereas mutation
of the Glu residue in repeat IV had dramatic effects,
the equivalent mutation in repeat I was essentially si-
lent. This is probably a manifestation of the fact that
other residues in repeat I also determine the strength
of the v-AgaIVA–channel interaction and, thus, the
toxin does not bind tightly to this repeat. An alternate
interpretation would be possible if the voltage-sensitive
conformational changes in repeat I are not strongly
coupled to channel activation. In this case, repeat I
might contain a fully competent v-Aga-IVA binding
Figure 3. Gating properties of mutant a1A Ca21 channels. (A)
Steady state current–voltage relations for wild-type and two mutant
Ca21 channels. Ba21 currents were measured 10 ms after depolar-
ization and have been normalized to the maximal inward current.
Charge carrier was 1 mM Ba21. Leak currents were subtracted us-
ing 100 mM Cd. (B) Normalized conductance–voltage (G-V) rela-
tions for wild-type and two mutants channels. G was calculated ac-
cording to G 5 IBa21/(V 2 Vrev) with Vrev 5 129 mV. Symbols are
means 6 SEM for four to ﬁve cells each. Smooth curves are single
Boltzmann ﬁts to the data with the following parameters: (wild-
type) z 5 6.8, V50 5 218.9 mV; (Glu188Lys) z 5 6.0, V50 5 211.9
mV; and (Glu1658Lys) z 5 5.8, V50 5 210.9 mV.
point mutations to locate the v-Aga-IVA receptor. The
predictive value of the K1 and Na1 channel toxin stud-
ies bolsters the idea that gating modiﬁer toxins interact
with a common region within the voltage-sensing do-
mains of voltage-gated ion channels.642 Common Binding Sites for Gating Modifier Toxins
site, but our measurements simply don’t allow us to de-
tect occupancy.
What is the stoichiometry of the v-AgaIVA–channel
interaction? The concentration dependence for frac-
tional inhibition of the channel by v-AgaIVA (Fig. 2)
deviated somewhat from that predicted for 1:1 stoichi-
ometry. However, this deviation is most pronounced at
low toxin concentrations where the binding kinetics are
very slow (ton z200 s at 125 nM toxin), possibly indicat-
ing a failure to reach equilibrium. We found that a sin-
gle point mutation in repeat IV essentially disrupts inhi-
bition by the toxin (Fig. 4). This result is consistent with
the existence of a single receptor for the toxin on the
Ca21 channel, but does not rule out a number of more
complex scenarios. It is possible that the toxin interacts
with one or more of the three other repeats (I–III) of
the Ca21 channel. If these hypothetical interactions ex-
ist, they probably do not alter activation gating in iso-
lation since the single point mutation in repeat IV
(Glu1658Lys) essentially disrupts the inhibitory effects
Figure 4. Altered interac-
tion of v-Aga-IVA with mu-
tant Ca21 channels. (A) Cur-
rent records elicited by depo-
larization in the absence and
presence of 1 mM v-Aga-IVA.
Depolarizations were elicited
to 215 mV for wild type and
to  210 mV for both
Glu188Lys and Glu1658Lys.
Holding voltage was 290 mV.
Charge carrier was 1 mM
Ba21. Leak and capacitive cur-
rents have been isolated and
subtracted using 100 mM Cd.
(B) Time course for effects of
1 mM v-Aga-IVA. Steady state
Ba21 current elicited by depo-
larizations to either 215 mV
(wild type) or 220 mV (both
mutants) at 10-s intervals be-
fore and after application of
toxin. Inward Ba21 currents
were measured 10 ms after
depolarization. (Same cells as
in A.) (C) Plot of fraction of
uninhibited ( ) current
against toxin concentration
for wild type, Glu188Lys, and
Glu1658Lys.   is the frac-
tion of uninhibited current in
the plateau phase at negative
voltages, typically 225 to 25
mV (Fig. 2 C). Smooth curves
are ﬁts of    5  1 –
{[toxin]/([toxin]  1  Kd)} to
the data, where Kd is the equi-
librium dissociation constant
for single toxin binding sites.
Kd values are as follows: 160
nM for wild-type; 110 nM for
Glu188Lys; and 33 mM for
Glu1658Lys. Data are means 6
SEM for between three and
eight oocytes at each toxin
concentration. Data for wild
type are from Fig. 2.
In/I
n
0
In/I
n
0
In/I
n
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of the toxin. Nevertheless, it is conceivable that toxin
occupancy of repeats I, II, or III may be required for
the inhibitory effect of the toxin on repeat IV.
Although the gating modiﬁer toxins may interact
with similar regions, it is interesting that some of these
toxins have very different effects on channel gating.
The toxins that bind to Na1 channels slow inactivation,
whereas the K1 and Ca21 channel toxins inhibit their
channels by shifting activation to more depolarized
voltages. In the case of Kurtoxin, the same molecule
can elicit these two different effects: one when it binds
to T-type Ca21 channels, and the other when it binds to
Na1 channels (Chuang et al., 1998). One possibility is
that the toxins exert different inﬂuences on the confor-
mational rearrangements of the voltage-sensing do-
mains in Na1 channels versus K1 and Ca21 channels.
An alternate explanation is that the effects of the toxins
on the voltage-sensing domains are very similar, but it is
the processes that the domains inﬂuence that are dif-
ferent. Thus, the voltage-sensing domain in repeat IV
of the Na1 channel might couple to channel inacti-
vation as previously proposed (Sheets et al., 1999),
whereas the equivalent repeat in the Ca21 channel may
couple to channel activation. The differential coupling
of voltage-sensing domains to distinct gating processes
seems less likely for K1 channels given their fourfold
symmetry. For all three channel types, the gating modi-
ﬁer toxins might perturb the conformational rear-
rangements in the voltage-sensing domains by stabiliz-
ing the resting conformation that predominates at
negative voltages. This idea is supported by the observa-
tions that both the K1 and Na1 channel toxins inhibit
gating currents in their respective channels (Nonner,
1979; Meves et al., 1987; Sheets and Hanck, 1995;
Swartz, 1999) in spite of the fact that their effects on ac-
tivation and inactivation are quite distinct.
It is interesting to consider why the gating modiﬁer
toxins target such a well-deﬁned region within the volt-
age-sensing domains in different voltage-gated ion chan-
nels. In principle, there could be many distinct sites
within the voltage-sensing domains from which different
gating modiﬁer toxins could alter the conformational re-
arrangements of the underlying protein. Yet, this seems
not to be the case, at least not as a rule. One explanation
might be that the conformational rearrangements oc-
curring in the voltage-sensing domains are both spatially
restricted and subtle. The gating modiﬁer toxins might
have evolved the ability to recognize a localized region
where structural rearrangements can be most readily
perturbed through protein–protein interactions.
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